SVB Wealth LLC Buys New Stake in Marsh & McLennan Companies, Inc. $MRSH

Marsh & McLennan Companies logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • SVB Wealth LLC opened a new position in Marsh & McLennan Companies during the first quarter, buying 18,369 shares worth about $3.19 million.
  • The company reported better-than-expected quarterly earnings of $3.29 per share, topping estimates, while revenue rose 7.6% year over year to $7.30 billion.
  • Shares were down 1.3% in Tuesday trading, and the stock has attracted mixed analyst views, with the consensus rating at Hold and an average price target of $200.19.
  • Interested in Marsh & McLennan Companies? Here are five stocks we like better.

SVB Wealth LLC purchased a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 18,369 shares of the financial services provider's stock, valued at approximately $3,186,000.

A number of other institutional investors have also recently made changes to their positions in MRSH. Numerai GP LLC raised its stake in Marsh & McLennan Companies by 966.2% during the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider's stock valued at $7,501,000 after purchasing an additional 33,729 shares in the last quarter. Swiss Life Asset Management Ltd increased its holdings in shares of Marsh & McLennan Companies by 9.5% in the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider's stock worth $24,960,000 after buying an additional 11,648 shares during the last quarter. Barclays PLC raised its position in shares of Marsh & McLennan Companies by 41.7% during the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider's stock valued at $443,844,000 after buying an additional 647,987 shares in the last quarter. Sarasin & Partners LLP lifted its holdings in shares of Marsh & McLennan Companies by 0.9% in the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider's stock valued at $173,411,000 after acquiring an additional 8,283 shares during the last quarter. Finally, CSM Advisors LLC purchased a new position in Marsh & McLennan Companies in the third quarter worth about $1,180,000. Hedge funds and other institutional investors own 87.99% of the company's stock.

Marsh & McLennan Companies Trading Down 1.3%

MRSH stock opened at $160.23 on Tuesday. Marsh & McLennan Companies, Inc. has a twelve month low of $156.60 and a twelve month high of $220.32. The firm has a market capitalization of $77.41 billion, a price-to-earnings ratio of 20.03, a price-to-earnings-growth ratio of 2.37 and a beta of 0.62. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last issued its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.21 by $0.08. The firm had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. Marsh & McLennan Companies's quarterly revenue was up 7.6% compared to the same quarter last year. Analysts forecast that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. Barclays decreased their price objective on Marsh & McLennan Companies from $209.00 to $206.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 8th. Bank of America decreased their price target on Marsh & McLennan Companies from $181.00 to $174.00 and set an "underperform" rating on the stock in a report on Tuesday, April 14th. Keefe, Bruyette & Woods lifted their price objective on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a "market perform" rating in a research note on Friday, April 17th. Wells Fargo & Company reduced their target price on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 9th. Finally, Weiss Ratings cut shares of Marsh & McLennan Companies from a "hold (c)" rating to a "hold (c-)" rating in a research note on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Marsh & McLennan Companies presently has an average rating of "Hold" and an average target price of $200.19.

Read Our Latest Research Report on Marsh & McLennan Companies

Insider Buying and Selling

In other news, CEO John Q. Doyle sold 16,656 shares of the firm's stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the transaction, the chief executive officer directly owned 116,811 shares of the company's stock, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by corporate insiders.

About Marsh & McLennan Companies

(Free Report)

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Recommended Stories

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MRSH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines